The latest trading session saw UpHealth, Inc. (UPHL - Free Report) ending at $0.85, denoting a +1.31% adjustment from its last day's close. This move outpaced the S&P 500's daily loss of 1.57%. Elsewhere, the Dow saw a downswing of 1.49%, while the tech-heavy Nasdaq depreciated by 2.04%.
Shares of the company have depreciated by 20% over the course of the past month, underperforming the Medical sector's loss of 6.09% and the S&P 500's loss of 2.5%.
Market participants will be closely following the financial results of UpHealth, Inc. in its upcoming release.
Investors might also notice recent changes to analyst estimates for UpHealth, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 112.93% higher within the past month. UpHealth, Inc. is holding a Zacks Rank of #1 (Strong Buy) right now.
In terms of valuation, UpHealth, Inc. is presently being traded at a Forward P/E ratio of 5.6. This represents a discount compared to its industry's average Forward P/E of 17.88.
The Medical Services industry is part of the Medical sector. This group has a Zacks Industry Rank of 85, putting it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow UPHL in the coming trading sessions, be sure to utilize Zacks.com.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
The latest trading session saw UpHealth, Inc. (UPHL - Free Report) ending at $0.85, denoting a +1.31% adjustment from its last day's close. This move outpaced the S&P 500's daily loss of 1.57%. Elsewhere, the Dow saw a downswing of 1.49%, while the tech-heavy Nasdaq depreciated by 2.04%.
Shares of the company have depreciated by 20% over the course of the past month, underperforming the Medical sector's loss of 6.09% and the S&P 500's loss of 2.5%.
Market participants will be closely following the financial results of UpHealth, Inc. in its upcoming release.
Investors might also notice recent changes to analyst estimates for UpHealth, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 112.93% higher within the past month. UpHealth, Inc. is holding a Zacks Rank of #1 (Strong Buy) right now.
In terms of valuation, UpHealth, Inc. is presently being traded at a Forward P/E ratio of 5.6. This represents a discount compared to its industry's average Forward P/E of 17.88.
The Medical Services industry is part of the Medical sector. This group has a Zacks Industry Rank of 85, putting it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow UPHL in the coming trading sessions, be sure to utilize Zacks.com.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on UPHL - FREE